Abstract: . . .  Lancet 1996;347(9001):561-568. 5. Stone GW. Impact of new pharmacologic agents in the treatment of acute thrombotic syndromes. Am J Cardiol 1999;83(9A):16E-20E. Page 7 Rev Med IMSS 2004; 42 (1): 61-67 67 Eduardo Salazar Weil. Experiencia en infarto del miocardio 6. Mark DB, Cowper PA, Berdowitz SD, Davidson RL, Turpie AG, Califf RM, Cohen M. Economic assessment of low molecular heparin versus un- fractionated heparin in acute coronary syndrome patients. Circulation 1998;97(17):1702-1707.  . . .
. . .  mized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-682. 25. Kucharoya L, Cagan S. The electrocardiogram in acute myocardial infarction in the thrombolyticera. Bratils Lek Lesty 1996;97(7):138-146. 26. Salazar WE. Tratamiento tromboltico en el infarto del miocardio . Rev Med IMSS 1998;36(5):345-348. 27. Futterman LG, Lemberg L. Low molecular weight heparin: an antithrombotic agent whose time has come. Am J Crit Care 1999;8(1):520-523. 28. Salazar WE. Enoxaparina y heparina no fraccionada . . .
. . .  tromboltico en el infarto del miocardio . Rev Med IMSS 1998;36(5):345-348. 27. Futterman LG, Lemberg L. Low molecular weight heparin: an antithrombotic agent whose time has come. Am J Crit Care 1999;8(1):520-523. 28. Salazar WE. Enoxaparina y heparina no fraccionada en infarto del miocardio no trombolisado. Rev Med IMSS 2001;39(3):207-213. 29. Ridgway PF, Crosbie J, Hinedi KA, Gladban W. Unfractionated heparin, time for a change? Ir Med J 1999;92(3):302-306. 30. Armstrong PW. Heparin in acute coronary disease. Requiem for a heavy weigth? N Engl . . .
. . .  tromboltico en el infarto del miocardio . Rev Med IMSS 1998;36(5):345-348. 27. Futterman LG, Lemberg L. Low molecular weight heparin: an antithrombotic agent whose time has come. Am J Crit Care 1999;8(1):520-523. 28. Salazar WE. Enoxaparina y heparina no fraccionada en infarto del miocardio no trombolisado. Rev Med IMSS 2001;39(3):207-213. 29. Ridgway PF, Crosbie J, Hinedi KA, Gladban W. Unfractionated heparin, time for a change? Ir Med J 1999;92(3):302-306. 30. Armstrong PW. Heparin in acute coronary disease. Requiem for a heavy weigth? . . .
. . .  tromboltico en el infarto del miocardio . Rev Med IMSS 1998;36(5):345-348. 27. Futterman LG, Lemberg L. Low molecular weight heparin: an antithrombotic agent whose time has come. Am J Crit Care 1999;8(1):520-523. 28. Salazar WE. Enoxaparina y heparina no fraccionada en infarto del miocardio no trombolisado. Rev Med IMSS 2001;39(3):207-213. 29. Ridgway PF, Crosbie J, Hinedi KA, Gladban W. Unfractionated heparin, time for a change? Ir Med J 1999;92(3):302-306. 30. Armstrong PW. Heparin in acute coronary disease. Requiem for a heavy weigth? N Engl . . .
--3000,5,300,3393,33941